Nektar Therapeutics NKTR Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nektar Therapeutics's other non-current liabilities?
- Nektar Therapeutics (NKTR) reported other non-current liabilities of $8.45M in Q1 2026.
- How has Nektar Therapeutics's other non-current liabilities changed year-over-year?
- Nektar Therapeutics's other non-current liabilities increased by 25.0% year-over-year, from $6.76M to $8.45M.
- What is the long-term trend for Nektar Therapeutics's other non-current liabilities?
- Over 5 years (2020 to 2025), Nektar Therapeutics's other non-current liabilities has grown at a -0.8% compound annual growth rate (CAGR), from $8.98M to $8.63M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.